{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:52:32Z","timestamp":1794617552619,"version":"4.9.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"13","funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry, and Energy (MOTIE) of the Republic of Korea","doi-asserted-by":"publisher","award":["20194010201750"],"award-info":[{"award-number":["20194010201750"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Glycogen syntheis kinase (GSK-3) inhibitors are novel therapeutic agents\nfor treating various types of cancer, such as breast, lung, and gastric cancer. No pathological\nchanges have been found by the morphological examination of GSK-3.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>This review describes recent procedures using GSK-3 inhibitors, primarily in treating\ncolon carcinoma. Furthermore, it also explains the mechanism of action of different GSK-3 inhibitors\nin treating various types of cancers and proposes some additional mechanisms may be useful\nfor further research on GSK-3 inhibitors for cancers, including colon carcinoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The majority of the cancerous and pre-cancerous lesions are stimulated by the transformation\nof membrane-bound arachidonic acid (AA) to eicosanoids, a transformation that promotes for\nthe viability, proliferation, and spread of cancer. GSK-3 inhibitors can reinstate hostility to tumor\nnecrosis factor-related apoptosis-inducing ligand (TRAIL) responsiveness in gastric adenocarcinoma\ncells. GSK-3, the final enzyme in glycogen synthesis, is a serine\/threonine kinase that phosphorylates\nvaried sequences that are more than a hundred in number, within proteins in an array of\nheterogeneous pathways. It is an essential module of an exceptionally large number of cellular processes,\nplaying a fundamental role in many metabolic processes and diseases. Many patients diagnosed\nwith colon cancer achieve long-term remission with outstanding survival through the GSK-3\ninhibitors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Prior to the extensive application of these proposed mechanisms of GSK-3 inhibitor,\nfurther evaluation and clinical studies are needed. Only after the completion of appropriate clinical\nstudies and morphological examinations, would extensive application be apprpriate.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450122666210204203950","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T06:10:38Z","timestamp":1612764638000},"page":"1485-1495","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-4830","authenticated-orcid":true,"given":"Sitansu S.","family":"Nanda","sequence":"first","affiliation":[{"name":"Department of Chemistry, Myongji University, Yongin, 03674, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md I.","family":"Hossain","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Myongji University, Yongin, 03674, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-7864","authenticated-orcid":true,"given":"Heongkyu","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Physics, Gachon University, Seongnam-si, Gyeonggi-do, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia C.","family":"Papaefthymiou","sequence":"additional","affiliation":[{"name":"Department of Physics, Villanova University, Villanova, Pennsylvania\n19085, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-9323","authenticated-orcid":true,"given":"Dong K.","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Myongji University, Yongin, 03674, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450122666210204203950","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191175\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450122666210204203950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T13:30:02Z","timestamp":1659619802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191175\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450122666210204203950","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}